BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34561174)

  • 1. Intensity modulated high dose rate ocular brachytherapy using Se-75.
    Dupere JM; Munro JJ; Medich DC
    Brachytherapy; 2021; 20(6):1312-1322. PubMed ID: 34561174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shielded high dose rate ocular brachytherapy using Yb-169.
    Dupere JM; Munro JJ; Medich DC
    Phys Med Biol; 2021 Jun; 66(12):. PubMed ID: 34010825
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of
    Safigholi H; Meigooni AS; Song WY
    Med Phys; 2017 Sep; 44(9):4426-4436. PubMed ID: 28494095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
    Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
    Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between beta radiation dose distribution due to LDR and HDR ocular brachytherapy applicators using GATE Monte Carlo platform.
    Mostafa L; Rachid K; Ahmed SM
    Phys Med; 2016 Aug; 32(8):1007-18. PubMed ID: 27499370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
    Lesperance M; Inglis-Whalen M; Thomson RM
    Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
    Lesperance M; Martinov M; Thomson RM
    Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate
    Ma Y; Vijande J; Ballester F; Tedgren ÅC; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith R; Chamberland MJP; Thomson RM; Verhaegen F; Beaulieu L
    Med Phys; 2017 Nov; 44(11):5961-5976. PubMed ID: 28722180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
    Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
    Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
    Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
    Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
    Jiang H; Badkul R; Pokhrel D
    J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDR brachytherapy of rectal cancer using a novel grooved-shielding applicator design.
    Webster MJ; Devic S; Vuong T; Han DY; Scanderbeg D; Choi D; Song B; Song WY
    Med Phys; 2013 Sep; 40(9):091704. PubMed ID: 24007137
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hadadi A; Ghanavati S
    Appl Radiat Isot; 2023 Jul; 197():110786. PubMed ID: 37023694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose characteristics of Au-198 eye brachytherapy applicator: A Monte Carlo study.
    Kamrani S; Aghamiri SMR; Hashemi S
    Appl Radiat Isot; 2021 Oct; 176():109866. PubMed ID: 34293507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
    Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
    Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
    Gagne NL; Leonard KL; Rivard MJ
    Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of dose distribution in ocular brachytherapy with
    Zabihzadeh M; Rezaee H; Hosseini SM; Feghhi M; Danyaei A; Hoseini-Ghahfarokhi M
    J Cancer Res Ther; 2019; 15(3):504-511. PubMed ID: 31169211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMS eye plaque brachytherapy dosimetric sensitivity to source photon energy and seed design.
    Gagne NL; Rivard MJ
    Appl Radiat Isot; 2013 Sep; 79():62-6. PubMed ID: 23728350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
    Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
    Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monte Carlo dosimetry modeling of focused kV x-ray radiotherapy of eye diseases with potential nanoparticle dose enhancement.
    Yan H; Ma X; Sun W; Mendez S; Stryker S; Starr-Baier S; Delliturri G; Zhu D; Nath R; Chen Z; Roberts K; MacDonald CA; Liu W
    Med Phys; 2018 Oct; 45(10):4720-4733. PubMed ID: 30133705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.